BIRC5 and neoplasm: In ovarian and kidney cancer, survivin increases the aggressiveness of tumors by promoting the epithelial-mesenchymal transition (EMT) of tumor cells [6], but the mechanism that controls its nuclear-cytoplasmic localization remains unclear.